Increasing bladder capacity and vesicoureteral reflux in pediatric kidney transplant patients.


Journal

International journal of urology : official journal of the Japanese Urological Association
ISSN: 1442-2042
Titre abrégé: Int J Urol
Pays: Australia
ID NLM: 9440237

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 09 05 2020
accepted: 09 07 2020
pubmed: 14 8 2020
medline: 28 4 2021
entrez: 14 8 2020
Statut: ppublish

Résumé

To investigate the frequency of vesicoureteral reflux, and the relationship of pretransplant decreased bladder capacity and post-transplant vesicoureteral reflux in children undergoing kidney transplantation. A voiding cystourethrography was carried out in 172 pediatric kidney transplantation recipients before, and 4 months after, transplantation to evaluate bladder capacity and vesicoureteral reflux. The correlation of post-transplant vesicoureteral reflux with pretransplant bladder capacity, vesicoureteral reflux in the native kidney and the method of ureteral reimplantation (intravesical/extravesical) was analyzed. Atrophic bladder was defined as having ≤50% functional bladder capacity (age in years + 2) × 25 (mL) or ≤150 mL in patients aged >10 years. Bladder capacity increased remarkably after transplantation in both post-transplant vesicoureteral reflux- group (from 180 to 253 mL) and vesicoureteral reflux+ group (from 82 to 171 mL). Voiding cystourethrography showed vesicoureteral reflux in 12 cases of kidney transplantation (7%; grade 1: 2, grade 2: 3, grade 3: 7). Pretransplant atrophic bladder was an independent risk factor of post-transplant vesicoureteral reflux (P = 0.004, hazard ratio 9.5). There was no difference in renal function between the vesicoureteral reflux- group and vesicoureteral reflux+ group at 4 months to 5 years post-transplantation. Pretransplant atrophic bladder is a risk factor of post-transplant vesicoureteral reflux in pediatric patients. However, bladder capacity can remarkably increase after transplantation, and kidney function in the post-transplant vesicoureteral reflux+ group is stable.

Identifiants

pubmed: 32789949
doi: 10.1111/iju.14348
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1008-1012

Informations de copyright

© 2020 The Japanese Urological Association.

Références

Fontana I, Ginevri F, Arcuri V et al. Vesico-ureteral reflux in pediatric kidney transplants: clinical relevance to graft and patient outcome. Pediatr. Transplant. 1999; 3: 206-9.
Barrero R, Fijo J, Fernandez-Hurtado M, García-Merino F, León E, Torrubia F. Vesicoureteral reflux after kidney transplantation in children. Pediatr. Transplant. 2007; 11: 498-503.
Irtan S, Maisin A, Baudouin V et al. Renal transplantation in children: critical analysis of age related surgical complications. Pediatr. Transplant. 2010; 14: 512-9.
Wu HY, Concepcion W, Grimm PC. When does vesicoureteral reflux in pediatric kidney transplant patients need treatment? Pediatr. Transplant. 2018; 22: e13299.
Torricelli FC, Watanabe A, Piovesan AC, Antonopoulos IM, David-Neto E, Nahas WC. Urological complications, vesicoureteral reflux, and long-term graft survival rate after pediatric kidney transplantation. Pediatr. Transplant. 2015; 19: 844-8.
Sjöström S, Sillén U, Bachelard M, Hansson S, Stokland E. Spontaneous resolution of high grade infantile vesicoureteral reflux. J. Urol. 2004; 172: 694-8.
Sidhu G, Beyene J, Rosenblum ND. Outcome of isolated antenatal hydronephrosis:a systematic review and meta-analysis. Pediatr. Nephrol. 2006; 21: 218-24.
Mathew TH, Kincaid-Smith P, Vikraman P. Risks of vesicoureteric reflux in the transplanted kidney. N. Engl. J. Med. 1977; 297: 414-8.
Dunn SP, Vinocur CD, Hanevold C, Wagner CW, Weintraub WH. Pyelonephritis following pediatric renal transplant: increased incidence with vesicoureteral reflux. J. Pediatr. Surg. 1987; 22: 1095-9.
Peters CA, Skoog SJ, Arant BS Jr et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J. Urol. 2010; 184: 1134-44.
Tekgül S, Riedmiller H, Hoebeke P et al.; European Association of Urology. EAU guidelines on vesicoureteral reflux in children. Eur. Urol. 2012; 62: 534-42.
Hoebeke P, Van Laecke E, Van Camp C, Raes A, Van De Walle J. One thousand video-urodynamic studies in children with non-neurogenic bladder sphincter dysfunction. BJU Int. 2001; 87: 575-80.
Kass EJ, Koff SA, Diokno AC. Fate of vesicoureteral reflux in children with neuropathic bladders managed by intermittent catheterization. J. Urol. 1981; 125: 63-4.
Inoue T, Satoh S, Saito M et al. Correlations between pretransplant dialysis duration, bladder capacity, and prevalence of vesicoureteral reflux to the graft. Transplantation 2011; 92: 311-5.
Hamano S, Yamanishi T, Igarashi T, Murakami S, Ito H. Evaluation of functional bladder capacity in Japanese children. Int. J. Urol. 1999; 6: 226-8.
Uemura O, Nagai T, Ishikura K et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin. Exp. Nephrol. 2014; 18: 626-33.
Hotta K, Miura M, Wada Y et al. Atrophic bladder in long-term dialysis patients increases the risk for urological complications after kidney transplantation. Int. J. Urol. 2017; 24: 314-9.
Kashi SH, Wynne KS, Sadek SA, Lodge JP. An evaluation of vesical urodynamics before renal transplantation and its effect on renal allograft function and survival. Transplantation 1994; 57: 1455-7.
Martin X, Aboutaieb R, Soliman S, el Essawy A, Dawahra M, Lefrancois N. The use of long-term defunctionalized bladder in renal transplantation: is it safe? Eur. Urol. 1999; 36: 450-3.
Chun JM, Jung GO, Park JB et al. Renal transplantation in patients with a small bladder. Transplant. Proc. 2008; 40: 2333-5.
Serrano DP, Flechner SM, Modlin CS, Wyner LM, Novick AC. Transplantation into the long-term defunctionalized bladder. J. Urol. 1996; 156: 885-8.
Tanagho EA. Congenitally obstructed bladders: fate after prolonged defunctionalization. J. Urol. 1974; 111: 102-9.
Akioka Y, Chikamoto H, Horita S et al. Screening of vesicoureteral reflux in pediatric patients with kidney transplantation showing non-specific interstitial fibrosis and tubular atrophy with interstitial Tamm-Horsfall protein deposits in protocol allograft biopsy. Clin. Transplant. 2009; 23: 2-5.
Luke PP, Herz DB, Bellinger MF et al. Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract. Transplantation 2003; 76: 1578-82.
Routh JC, Yu RN, Kozinn SI, Nguyen HT, Borer JG. Urological complications and vesicoureteral reflux following pediatric kidney transplantation. J. Urol. 2013; 189: 1071-6.
Smith KM, Windsperger A, Alanee S, Humar A, Kashtan C, Shukla AR. Risk factors and treatment success for ureteral obstruction after pediatric renal transplantation. J. Urol. 2010; 183: 317-22.
Englesbe MJ, Lynch RJ, Heidt DG et al. Early urologic complications after pediatric renal transplant: a single-center experience. Transplantation 2008; 86: 1560-4.
Saad IR, Habib E, ElSheemy MS et al. Outcomes of living donor renal transplantation in children with lower urinary tract dysfunction: a comparative retrospective study. BJU Int. 2016; 118: 320-6.
Silva DM, Prudente AC, Mazzali M, Borges CF, D’Ancona C. Bladder function evaluation before renal transplantation in nonurologic disease: is it necessary? Urology 2014; 83: 406-10.
Rude T, Nassiri N, Naser-Tavakolian A, Ginsberg D. The role of urodynamics in the pre-transplant evaluation of renal transplant. Curr. Urol. Rep. 2019; 20: 26.

Auteurs

Yosuke Morizawa (Y)

Departments of, Department of, Urology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Hiroyuki Satoh (H)

Departments of, Department of, Urology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Shun Iwasa (S)

Departments of, Department of, Urology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Atsuko Sato (A)

Departments of, Department of, Urology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Yujiro Aoki (Y)

Departments of, Department of, Urology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Ryoko Harada (R)

Department of, Nephrology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Riku Hamada (R)

Department of, Nephrology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Hiroshi Hataya (H)

Department of, Nephrology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH